Biohaven Pharmaceutical Holding Co Ltd.
BHVN
Transaktioner
350
Köp
168
Sälj
182
Nettoinsynsflöde
-2.0 mdr USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
350 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2022-10-03 | Bailey Gregory | Director | Sell | 2.6 mn | 148,50 | 383.7 mn USD |
| 2022-10-03 | Gentile Kimberly | SVP, Clinical Operations | Sell | 12 k | 148,50 | 1.7 mn USD |
| 2022-10-03 | Conway Charles | Chief Scientific Officer | Sell | 22 k | 148,50 | 3.3 mn USD |
| 2022-10-03 | Stock Elyse | Chief Medical Officer | Sell | 11 k | 148,50 | 1.6 mn USD |
| 2022-10-03 | Stock Elyse | Chief Medical Officer | Sell | 5 k | 148,50 | 798 k USD |
| 2022-10-03 | Clark George C. | VP, Chief Accounting Officer | Sell | 4 k | 148,50 | 637 k USD |
| 2022-10-03 | Bailey Gregory | Director | Sell | 2.6 mn | 148,50 | 383.7 mn USD |
| 2022-10-03 | Engelhart James | Strategic Advisor | Sell | 16 k | 148,50 | 2.4 mn USD |
| 2022-10-03 | Tilton John | Chief Commercial Officer | Sell | 5 k | 148,50 | 753 k USD |
| 2022-10-03 | Tilton John | Chief Commercial Officer | Sell | 2 k | 148,50 | 240 k USD |
| 2022-10-03 | Mehta Kishan | Director | Sell | 11 k | 148,50 | 1.6 mn USD |
| 2022-10-03 | Buten Matthew | Chief Financial Officer | Sell | 6 k | 148,50 | 917 k USD |
| 2022-10-03 | HUGIN ROBERT J | Director | Sell | 3 k | 148,50 | 431 k USD |
| 2022-10-03 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 14 k | 148,50 | 2.1 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 92 k | 148,50 | 13.7 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 314 k | 148,50 | 46.6 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 19 k | 148,50 | 2.8 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 498 k | 148,50 | 74.0 mn USD |
| 2022-10-03 | CHILDS JOHN W | Director | Sell | 3.0 mn | 148,50 | 449.2 mn USD |
| 2022-10-03 | CHILDS JOHN W | Director | Sell | 10 k | 148,50 | 1.5 mn USD |
| 2022-10-03 | Buten Matthew | Chief Financial Officer | Sell | 6 k | 148,50 | 917 k USD |
| 2022-10-03 | CHILDS JOHN W | Director | Sell | 3.0 mn | 148,50 | 449.2 mn USD |
| 2022-10-03 | CHILDS JOHN W | Director | Sell | 10 k | 148,50 | 1.5 mn USD |
| 2022-10-03 | Clark George C. | VP, Chief Accounting Officer | Sell | 4 k | 148,50 | 637 k USD |
| 2022-10-03 | Conway Charles | Chief Scientific Officer | Sell | 22 k | 148,50 | 3.3 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 92 k | 148,50 | 13.7 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 314 k | 148,50 | 46.6 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 19 k | 148,50 | 2.8 mn USD |
| 2022-10-03 | Coric Vlad | Chief Executive Officer | Sell | 498 k | 148,50 | 74.0 mn USD |
| 2022-10-03 | Engelhart James | Strategic Advisor | Sell | 16 k | 148,50 | 2.4 mn USD |
| 2022-10-03 | Gentile Kimberly | SVP, Clinical Operations | Sell | 12 k | 148,50 | 1.7 mn USD |
| 2022-10-03 | HUGIN ROBERT J | Director | Sell | 3 k | 148,50 | 431 k USD |
| 2022-10-03 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 14 k | 148,50 | 2.1 mn USD |
| 2022-10-03 | Mehta Kishan | Director | Sell | 11 k | 148,50 | 1.6 mn USD |
| 2022-10-03 | Stock Elyse | Chief Medical Officer | Sell | 11 k | 148,50 | 1.6 mn USD |
| 2022-10-03 | Stock Elyse | Chief Medical Officer | Sell | 5 k | 148,50 | 798 k USD |
| 2022-10-03 | Tilton John | Chief Commercial Officer | Sell | 5 k | 148,50 | 753 k USD |
| 2022-10-03 | Tilton John | Chief Commercial Officer | Sell | 2 k | 148,50 | 240 k USD |
| 2022-08-19 | Bailey Gregory | Director | Buy | 38 k | 148,04 | 5.6 mn USD |
| 2022-08-19 | Bailey Gregory | Director | Buy | 38 k | 148,04 | 5.6 mn USD |
| 2022-05-10 | Clark George C. | VP, Chief Accounting Officer | Buy | 2 k | 53,76 | 121 k USD |
| 2022-05-10 | Clark George C. | VP, Chief Accounting Officer | Sell | 4 k | 141,50 | 594 k USD |
| 2022-05-10 | Clark George C. | VP, Chief Accounting Officer | Buy | 2 k | 53,76 | 121 k USD |
| 2022-05-10 | Clark George C. | VP, Chief Accounting Officer | Sell | 4 k | 141,50 | 594 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Buy | 4 k | 53,76 | 202 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Buy | 2 k | 32,42 | 62 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 3 k | 114,93 | 367 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 2 k | 116,02 | 250 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 500 | 118,05 | 59 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 4 k | 119,37 | 420 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Buy | 4 k | 53,76 | 202 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Buy | 2 k | 32,42 | 62 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 3 k | 114,93 | 367 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 2 k | 116,02 | 250 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 500 | 118,05 | 59 k USD |
| 2022-01-19 | Clark George C. | VP, Chief Accounting Officer | Sell | 4 k | 119,37 | 420 k USD |
| 2022-01-10 | Mehta Kishan | Director | Buy | 2 k | 0,00 | 0 USD |
| 2022-01-10 | Stock Elyse | Chief Medical Officer | Buy | 937 | 0,00 | 0 USD |
| 2022-01-10 | Clark George C. | VP, Chief Accounting Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-10 | Clark George C. | VP, Chief Accounting Officer | Sell | 464 | 128,87 | 60 k USD |
| 2022-01-10 | Clark George C. | VP, Chief Accounting Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-10 | Clark George C. | VP, Chief Accounting Officer | Sell | 464 | 128,87 | 60 k USD |
| 2022-01-10 | Mehta Kishan | Director | Buy | 2 k | 0,00 | 0 USD |
| 2022-01-10 | Stock Elyse | Chief Medical Officer | Buy | 937 | 0,00 | 0 USD |
| 2022-01-07 | Coric Vlad | Chief Executive Officer | Buy | 10 k | 0,00 | 0 USD |
| 2022-01-07 | Coric Vlad | Chief Executive Officer | Sell | 5 k | 128,87 | 597 k USD |
| 2022-01-07 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-07 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 2 k | 128,87 | 210 k USD |
| 2022-01-07 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 0,00 | 0 USD |
| 2022-01-07 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 128,87 | 198 k USD |
| 2022-01-07 | Stock Elyse | Chief Medical Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-07 | Engelhart James | Strategic Advisor | Buy | 3 k | 0,00 | 0 USD |
| 2022-01-07 | Engelhart James | Strategic Advisor | Sell | 1 k | 128,87 | 165 k USD |
| 2022-01-07 | Clark George C. | VP, Chief Accounting Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-07 | Clark George C. | VP, Chief Accounting Officer | Sell | 522 | 128,87 | 67 k USD |
| 2022-01-07 | Tilton John | Chief Commercial Officer | Buy | 875 | 0,00 | 0 USD |
| 2022-01-07 | Tilton John | Chief Commercial Officer | Sell | 342 | 128,87 | 44 k USD |
| 2022-01-07 | Clark George C. | VP, Chief Accounting Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-07 | Clark George C. | VP, Chief Accounting Officer | Sell | 522 | 128,87 | 67 k USD |
| 2022-01-07 | Coric Vlad | Chief Executive Officer | Buy | 10 k | 0,00 | 0 USD |
| 2022-01-07 | Coric Vlad | Chief Executive Officer | Sell | 5 k | 128,87 | 597 k USD |
| 2022-01-07 | Engelhart James | Strategic Advisor | Buy | 3 k | 0,00 | 0 USD |
| 2022-01-07 | Engelhart James | Strategic Advisor | Sell | 1 k | 128,87 | 165 k USD |
| 2022-01-07 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-07 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 2 k | 128,87 | 210 k USD |
| 2022-01-07 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 0,00 | 0 USD |
| 2022-01-07 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 128,87 | 198 k USD |
| 2022-01-07 | Stock Elyse | Chief Medical Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-07 | Tilton John | Chief Commercial Officer | Buy | 875 | 0,00 | 0 USD |
| 2022-01-07 | Tilton John | Chief Commercial Officer | Sell | 342 | 128,87 | 44 k USD |
| 2022-01-06 | Coric Vlad | Chief Executive Officer | Buy | 13 k | 0,00 | 0 USD |
| 2022-01-06 | Coric Vlad | Chief Executive Officer | Sell | 6 k | 123,86 | 725 k USD |
| 2022-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 5 k | 0,00 | 0 USD |
| 2022-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 2 k | 123,86 | 276 k USD |
| 2022-01-06 | Stock Elyse | Chief Medical Officer | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 123,86 | 228 k USD |
| 2022-01-06 | Stock Elyse | Chief Medical Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-06 | Engelhart James | Strategic Advisor | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Engelhart James | Strategic Advisor | Sell | 2 k | 123,86 | 190 k USD |
| 2022-01-06 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 123,86 | 223 k USD |
| 2022-01-06 | Conway Charles | Chief Scientific Officer | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Conway Charles | Chief Scientific Officer | Sell | 2 k | 123,86 | 223 k USD |
| 2022-01-06 | Clark George C. | VP, Chief Accounting Officer | Buy | 875 | 0,00 | 0 USD |
| 2022-01-06 | Clark George C. | VP, Chief Accounting Officer | Sell | 409 | 123,86 | 51 k USD |
| 2022-01-06 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-06 | Tilton John | Chief Commercial Officer | Sell | 551 | 123,86 | 68 k USD |
| 2022-01-06 | Clark George C. | VP, Chief Accounting Officer | Buy | 875 | 0,00 | 0 USD |
| 2022-01-06 | Clark George C. | VP, Chief Accounting Officer | Sell | 409 | 123,86 | 51 k USD |
| 2022-01-06 | Conway Charles | Chief Scientific Officer | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Conway Charles | Chief Scientific Officer | Sell | 2 k | 123,86 | 223 k USD |
| 2022-01-06 | Coric Vlad | Chief Executive Officer | Buy | 13 k | 0,00 | 0 USD |
| 2022-01-06 | Coric Vlad | Chief Executive Officer | Sell | 6 k | 123,86 | 725 k USD |
| 2022-01-06 | Engelhart James | Strategic Advisor | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Engelhart James | Strategic Advisor | Sell | 2 k | 123,86 | 190 k USD |
| 2022-01-06 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 123,86 | 223 k USD |
| 2022-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 5 k | 0,00 | 0 USD |
| 2022-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 2 k | 123,86 | 276 k USD |
| 2022-01-06 | Stock Elyse | Chief Medical Officer | Buy | 4 k | 0,00 | 0 USD |
| 2022-01-06 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 123,86 | 228 k USD |
| 2022-01-06 | Stock Elyse | Chief Medical Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-06 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2022-01-06 | Tilton John | Chief Commercial Officer | Sell | 551 | 123,86 | 68 k USD |
| 2021-12-31 | Buten Matthew | Chief Financial Officer | Buy | 13 k | 0,00 | 0 USD |
| 2021-12-31 | Buten Matthew | Chief Financial Officer | Sell | 6 k | 137,81 | 871 k USD |
| 2021-12-31 | Buten Matthew | Chief Financial Officer | Buy | 13 k | 0,00 | 0 USD |
| 2021-12-31 | Buten Matthew | Chief Financial Officer | Sell | 6 k | 137,81 | 871 k USD |
| 2021-12-20 | GREGORY JULIA P | Director | Buy | 12 k | 23,63 | 284 k USD |
| 2021-12-20 | GREGORY JULIA P | Director | Sell | 12 k | 125,00 | 1.5 mn USD |
| 2021-12-20 | Clark George C. | VP, Chief Accounting Officer | Sell | 2 k | 123,84 | 237 k USD |
| 2021-12-20 | Clark George C. | VP, Chief Accounting Officer | Sell | 2 k | 123,84 | 237 k USD |
| 2021-12-20 | GREGORY JULIA P | Director | Buy | 12 k | 23,63 | 284 k USD |
| 2021-12-20 | GREGORY JULIA P | Director | Sell | 12 k | 125,00 | 1.5 mn USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Buy | 7 k | 20,79 | 145 k USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Buy | 15 k | 10,82 | 161 k USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Sell | 20 k | 105,43 | 2.1 mn USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 106,17 | 169 k USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Buy | 7 k | 20,79 | 145 k USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Buy | 15 k | 10,82 | 161 k USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Sell | 20 k | 105,43 | 2.1 mn USD |
| 2021-12-15 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 106,17 | 169 k USD |
| 2021-12-14 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 20,79 | 70 k USD |
| 2021-12-14 | Stock Elyse | Chief Medical Officer | Buy | 4 k | 10,82 | 39 k USD |
| 2021-12-14 | Stock Elyse | Chief Medical Officer | Sell | 7 k | 105,02 | 729 k USD |
| 2021-12-14 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 20,79 | 70 k USD |
| 2021-12-14 | Stock Elyse | Chief Medical Officer | Buy | 4 k | 10,82 | 39 k USD |
| 2021-12-14 | Stock Elyse | Chief Medical Officer | Sell | 7 k | 105,02 | 729 k USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Buy | 35 k | 0,00 | 0 USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Sell | 10 k | 102,01 | 1.0 mn USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Sell | 23 k | 102,70 | 2.4 mn USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Sell | 1 k | 103,85 | 144 k USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Buy | 35 k | 0,00 | 0 USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Sell | 10 k | 102,01 | 1.0 mn USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Sell | 23 k | 102,70 | 2.4 mn USD |
| 2021-12-10 | Engelhart James | Chief Financial Officer | Sell | 1 k | 103,85 | 144 k USD |
| 2021-11-29 | Doogan Declan | Director | Sell | 13 k | 112,40 | 1.5 mn USD |
| 2021-11-29 | Doogan Declan | Director | Sell | 11 k | 113,25 | 1.3 mn USD |
| 2021-11-29 | Doogan Declan | Director | Sell | 13 k | 112,40 | 1.5 mn USD |
| 2021-11-29 | Doogan Declan | Director | Sell | 11 k | 113,25 | 1.3 mn USD |
| 2021-11-26 | Clark George C. | VP, Chief Accounting Officer | Buy | 5 k | 0,00 | 0 USD |
| 2021-11-26 | Clark George C. | VP, Chief Accounting Officer | Sell | 2 k | 115,55 | 268 k USD |
| 2021-11-26 | Clark George C. | VP, Chief Accounting Officer | Buy | 5 k | 0,00 | 0 USD |
| 2021-11-26 | Clark George C. | VP, Chief Accounting Officer | Sell | 2 k | 115,55 | 268 k USD |
| 2021-11-25 | Conway Charles | Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2021-11-25 | Coric Vlad | Chief Executive Officer | Buy | 11 k | 0,00 | 0 USD |
| 2021-11-25 | Coric Vlad | Chief Executive Officer | Sell | 5 k | 115,55 | 586 k USD |
| 2021-11-25 | Engelhart James | Chief Financial Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-11-25 | Engelhart James | Chief Financial Officer | Sell | 2 k | 115,55 | 198 k USD |
| 2021-11-25 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2021-11-25 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 115,55 | 201 k USD |
| 2021-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 3 k | 0,00 | 0 USD |
| 2021-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 1 k | 115,55 | 151 k USD |
| 2021-11-25 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 0,00 | 0 USD |
| 2021-11-25 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 115,55 | 185 k USD |
| 2021-11-25 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2021-11-25 | Tilton John | Chief Commercial Officer | Sell | 492 | 115,55 | 57 k USD |
| 2021-11-25 | Conway Charles | Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2021-11-25 | Coric Vlad | Chief Executive Officer | Buy | 11 k | 0,00 | 0 USD |
| 2021-11-25 | Coric Vlad | Chief Executive Officer | Sell | 5 k | 115,55 | 586 k USD |
| 2021-11-25 | Engelhart James | Chief Financial Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-11-25 | Engelhart James | Chief Financial Officer | Sell | 2 k | 115,55 | 198 k USD |
| 2021-11-25 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2021-11-25 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 115,55 | 201 k USD |
| 2021-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 3 k | 0,00 | 0 USD |
| 2021-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 1 k | 115,55 | 151 k USD |
| 2021-11-25 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 0,00 | 0 USD |
| 2021-11-25 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 115,55 | 185 k USD |
| 2021-11-25 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2021-11-25 | Tilton John | Chief Commercial Officer | Sell | 492 | 115,55 | 57 k USD |
| 2021-11-23 | Conway Charles | Chief Scientific Officer | Buy | 10 k | 37,54 | 375 k USD |
| 2021-11-23 | Conway Charles | Chief Scientific Officer | Buy | 885 | 20,79 | 18 k USD |
| 2021-11-23 | Clark George C. | VP, Chief Accounting Officer | Buy | 2 k | 32,42 | 62 k USD |
| 2021-11-23 | Clark George C. | VP, Chief Accounting Officer | Buy | 2 k | 32,42 | 62 k USD |
| 2021-11-23 | Conway Charles | Chief Scientific Officer | Buy | 10 k | 37,54 | 375 k USD |
| 2021-11-23 | Conway Charles | Chief Scientific Officer | Buy | 885 | 20,79 | 18 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 250 k | 0,61 | 153 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 175 k | 5,60 | 980 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 50 k | 9,29 | 464 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 18 k | 28,76 | 518 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 18 k | 61,76 | 1.1 mn USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 30 k | 10,82 | 325 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 18 k | 47,10 | 848 k USD |
| 2021-11-16 | Doogan Declan | Director | Sell | 12 k | 115,90 | 1.4 mn USD |
| 2021-11-16 | Doogan Declan | Director | Sell | 18 k | 116,69 | 2.1 mn USD |
| 2021-11-16 | Doogan Declan | Director | Sell | 7 k | 117,87 | 834 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 250 k | 0,61 | 153 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 175 k | 5,60 | 980 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 50 k | 9,29 | 464 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 18 k | 28,76 | 518 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 18 k | 61,76 | 1.1 mn USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 30 k | 10,82 | 325 k USD |
| 2021-11-16 | Doogan Declan | Director | Buy | 18 k | 47,10 | 848 k USD |
| 2021-11-16 | Doogan Declan | Director | Sell | 12 k | 115,90 | 1.4 mn USD |
| 2021-11-16 | Doogan Declan | Director | Sell | 18 k | 116,69 | 2.1 mn USD |
| 2021-11-16 | Doogan Declan | Director | Sell | 7 k | 117,87 | 834 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 213 k | 0,61 | 130 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 150 k | 5,60 | 840 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 38 k | 9,29 | 350 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 18 k | 28,76 | 518 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 18 k | 61,76 | 1.1 mn USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 20 k | 10,82 | 216 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 18 k | 47,10 | 848 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 213 k | 0,61 | 130 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 150 k | 5,60 | 840 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 38 k | 9,29 | 350 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 18 k | 28,76 | 518 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 18 k | 61,76 | 1.1 mn USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 20 k | 10,82 | 216 k USD |
| 2021-11-15 | CHILDS JOHN W | Director | Buy | 18 k | 47,10 | 848 k USD |
| 2021-11-10 | CHILDS JOHN W | Director | Buy | 4 k | 122,75 | 477 k USD |
| 2021-11-10 | CHILDS JOHN W | Director | Buy | 1 k | 123,30 | 137 k USD |
| 2021-11-10 | CHILDS JOHN W | Director | Buy | 4 k | 122,75 | 477 k USD |
| 2021-11-10 | CHILDS JOHN W | Director | Buy | 1 k | 123,30 | 137 k USD |
| 2021-03-17 | CHILDS JOHN W | Director | Buy | 13 k | 76,00 | 1000 k USD |
| 2021-03-17 | CHILDS JOHN W | Director | Buy | 13 k | 76,00 | 1000 k USD |
| 2021-03-02 | CHILDS JOHN W | Director | Buy | 10 k | 85,14 | 851 k USD |
| 2021-03-02 | CHILDS JOHN W | Director | Buy | 10 k | 85,14 | 851 k USD |
| 2021-01-25 | CHILDS JOHN W | Director | Buy | 6 k | – | – |
| 2021-01-25 | CHILDS JOHN W | Director | Buy | 6 k | – | – |
| 2021-01-06 | Coric Vlad | Chief Executive Officer | Buy | 13 k | 0,00 | 0 USD |
| 2021-01-06 | Coric Vlad | Chief Executive Officer | Sell | 6 k | 83,38 | 484 k USD |
| 2021-01-06 | Conway Charles | Chief Scientific Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Conway Charles | Chief Scientific Officer | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Engelhart James | Chief Financial Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Engelhart James | Chief Financial Officer | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Stock Elyse | Chief Medical Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Stock Elyse | Chief Medical Officer | Buy | 1 k | 0,00 | 0 USD |
| 2021-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 5 k | 0,00 | 0 USD |
| 2021-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 2 k | 83,38 | 177 k USD |
| 2021-01-06 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2021-01-06 | Tilton John | Chief Commercial Officer | Sell | 492 | 83,38 | 41 k USD |
| 2021-01-06 | Conway Charles | Chief Scientific Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Conway Charles | Chief Scientific Officer | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Coric Vlad | Chief Executive Officer | Buy | 13 k | 0,00 | 0 USD |
| 2021-01-06 | Coric Vlad | Chief Executive Officer | Sell | 6 k | 83,38 | 484 k USD |
| 2021-01-06 | Engelhart James | Chief Financial Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Engelhart James | Chief Financial Officer | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 5 k | 0,00 | 0 USD |
| 2021-01-06 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 2 k | 83,38 | 177 k USD |
| 2021-01-06 | Stock Elyse | Chief Medical Officer | Buy | 4 k | 0,00 | 0 USD |
| 2021-01-06 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 83,38 | 146 k USD |
| 2021-01-06 | Stock Elyse | Chief Medical Officer | Buy | 1 k | 0,00 | 0 USD |
| 2021-01-06 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2021-01-06 | Tilton John | Chief Commercial Officer | Sell | 492 | 83,38 | 41 k USD |
| 2020-11-25 | Conway Charles | Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2020-11-25 | Conway Charles | Chief Scientific Officer | Sell | 1 k | 90,14 | 123 k USD |
| 2020-11-25 | Coric Vlad | Chief Executive Officer | Buy | 11 k | 0,00 | 0 USD |
| 2020-11-25 | Coric Vlad | Chief Executive Officer | Sell | 5 k | 90,14 | 448 k USD |
| 2020-11-25 | Engelhart James | Chief Financial Officer | Buy | 4 k | 0,00 | 0 USD |
| 2020-11-25 | Engelhart James | Chief Financial Officer | Sell | 2 k | 90,14 | 151 k USD |
| 2020-11-25 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2020-11-25 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 90,14 | 153 k USD |
| 2020-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 3 k | 0,00 | 0 USD |
| 2020-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 1 k | 90,14 | 112 k USD |
| 2020-11-25 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 0,00 | 0 USD |
| 2020-11-25 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 90,14 | 138 k USD |
| 2020-11-25 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2020-11-25 | Tilton John | Chief Commercial Officer | Sell | 480 | 90,14 | 43 k USD |
| 2020-11-25 | Conway Charles | Chief Scientific Officer | Buy | 3 k | 0,00 | 0 USD |
| 2020-11-25 | Conway Charles | Chief Scientific Officer | Sell | 1 k | 90,14 | 123 k USD |
| 2020-11-25 | Coric Vlad | Chief Executive Officer | Buy | 11 k | 0,00 | 0 USD |
| 2020-11-25 | Coric Vlad | Chief Executive Officer | Sell | 5 k | 90,14 | 448 k USD |
| 2020-11-25 | Engelhart James | Chief Financial Officer | Buy | 4 k | 0,00 | 0 USD |
| 2020-11-25 | Engelhart James | Chief Financial Officer | Sell | 2 k | 90,14 | 151 k USD |
| 2020-11-25 | Gentile Kimberly | SVP, Clinical Operations | Buy | 4 k | 0,00 | 0 USD |
| 2020-11-25 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 90,14 | 153 k USD |
| 2020-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 3 k | 0,00 | 0 USD |
| 2020-11-25 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 1 k | 90,14 | 112 k USD |
| 2020-11-25 | Stock Elyse | Chief Medical Officer | Buy | 3 k | 0,00 | 0 USD |
| 2020-11-25 | Stock Elyse | Chief Medical Officer | Sell | 2 k | 90,14 | 138 k USD |
| 2020-11-25 | Tilton John | Chief Commercial Officer | Buy | 1 k | 0,00 | 0 USD |
| 2020-11-25 | Tilton John | Chief Commercial Officer | Sell | 480 | 90,14 | 43 k USD |
| 2020-11-23 | CHILDS JOHN W | Director | Buy | 5 k | 89,55 | 448 k USD |
| 2020-11-23 | CHILDS JOHN W | Director | Buy | 5 k | 89,55 | 448 k USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 30 k | 50,72 | 1.5 mn USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 25 k | 76,02 | 1.9 mn USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 4 k | 77,01 | 309 k USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 1 k | 77,70 | 101 k USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Buy | 30 k | 50,72 | 1.5 mn USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 25 k | 76,02 | 1.9 mn USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 4 k | 77,01 | 309 k USD |
| 2020-11-02 | JONES WILLIAM A JR | CCO-Migraine & Common Disease | Sell | 1 k | 77,70 | 101 k USD |
| 2020-10-23 | Bailey Gregory | Director | Sell | 10 k | 78,89 | 804 k USD |
| 2020-10-23 | Bailey Gregory | Director | Sell | 212 | 79,94 | 17 k USD |
| 2020-10-23 | Bailey Gregory | Director | Sell | 10 k | 78,89 | 804 k USD |
| 2020-10-23 | Bailey Gregory | Director | Sell | 212 | 79,94 | 17 k USD |
| 2020-10-22 | Bailey Gregory | Director | Sell | 21 k | 79,41 | 1.7 mn USD |
| 2020-10-22 | Bailey Gregory | Director | Sell | 3 k | 79,88 | 248 k USD |
| 2020-10-22 | Bailey Gregory | Director | Sell | 21 k | 79,41 | 1.7 mn USD |
| 2020-10-22 | Bailey Gregory | Director | Sell | 3 k | 79,88 | 248 k USD |
| 2020-10-19 | Bailey Gregory | Director | Sell | 5 k | 78,98 | 360 k USD |
| 2020-10-19 | Bailey Gregory | Director | Sell | 5 k | 78,98 | 360 k USD |
| 2020-10-16 | Bailey Gregory | Director | Sell | 4 k | 78,88 | 296 k USD |
| 2020-10-16 | Bailey Gregory | Director | Sell | 4 k | 78,88 | 296 k USD |
| 2020-10-12 | Bailey Gregory | Director | Sell | 7 k | 78,87 | 531 k USD |
| 2020-10-12 | Bailey Gregory | Director | Sell | 7 k | 78,87 | 531 k USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Buy | 24 k | 9,29 | 218 k USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Sell | 5 k | 75,62 | 398 k USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Sell | 16 k | 76,42 | 1.2 mn USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 77,42 | 190 k USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Buy | 24 k | 9,29 | 218 k USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Sell | 5 k | 75,62 | 398 k USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Sell | 16 k | 76,42 | 1.2 mn USD |
| 2020-10-08 | Gentile Kimberly | SVP, Clinical Operations | Sell | 2 k | 77,42 | 190 k USD |
| 2020-09-21 | CHILDS JOHN W | Director | Buy | 3 k | 59,25 | 197 k USD |
| 2020-09-21 | CHILDS JOHN W | Director | Buy | 3 k | 59,25 | 197 k USD |
| 2020-09-11 | CHILDS JOHN W | Director | Buy | 7 k | 59,00 | 394 k USD |
| 2020-09-11 | CHILDS JOHN W | Director | Buy | 7 k | 59,00 | 394 k USD |
| 2020-08-11 | CHILDS JOHN W | Director | Buy | 3 k | 60,32 | 157 k USD |
| 2020-08-11 | CHILDS JOHN W | Director | Buy | 7 k | 61,28 | 446 k USD |
| 2020-08-11 | CHILDS JOHN W | Director | Buy | 15 k | 61,87 | 936 k USD |
| 2020-08-11 | CHILDS JOHN W | Director | Buy | 3 k | 60,32 | 157 k USD |
| 2020-08-11 | CHILDS JOHN W | Director | Buy | 7 k | 61,28 | 446 k USD |
| 2020-08-11 | CHILDS JOHN W | Director | Buy | 15 k | 61,87 | 936 k USD |
| 2020-07-08 | Bailey Gregory | Director | Sell | 44 k | 75,12 | 3.3 mn USD |
| 2020-07-08 | Bailey Gregory | Director | Sell | 6 k | 75,93 | 455 k USD |
| 2020-07-08 | Berman Robert | Special Projects & Med Ovrsght | Buy | 58 k | 0,61 | 36 k USD |
| 2020-07-08 | Berman Robert | Special Projects & Med Ovrsght | Sell | 56 k | 75,25 | 4.2 mn USD |
| 2020-07-08 | Berman Robert | Special Projects & Med Ovrsght | Sell | 3 k | 75,29 | 209 k USD |
| 2020-07-08 | Berman Robert | Special Projects & Med Ovrsght | Buy | 58 k | 0,61 | 36 k USD |
| 2020-07-08 | Berman Robert | Special Projects & Med Ovrsght | Sell | 56 k | 75,25 | 4.2 mn USD |
| 2020-07-08 | Berman Robert | Special Projects & Med Ovrsght | Sell | 3 k | 75,29 | 209 k USD |
| 2020-07-08 | Bailey Gregory | Director | Sell | 44 k | 75,12 | 3.3 mn USD |
| 2020-07-08 | Bailey Gregory | Director | Sell | 6 k | 75,93 | 455 k USD |

